Pathogenesis of thrombosis in coronary artery disease

Pathophysiology of Haemostasis and Thrombosis

Volumn 27, Issue 1, 1997, Pages 12-18

  Chesebro, James H ^a   Rauch, Ursula ^a   Fuster, Valentin ^a   Badimon, Juan J ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Low molecular weight heparins; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BLOOD RHEOLOGY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK MANAGEMENT; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; THROMBUS;

CORONARY DISEASE; HUMANS; LIPIDS; MACROPHAGES; RISK FACTORS; THROMBOSIS;

EID: 0030704305     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217477     Document Type: Article

References (36)

1. Falk E, Shah PK, Fustcr V: Coronary plaque disruption., Circulation 1995; 92:657-671.
2. Fuster V: Mechanisms leading to myocardial infarction: insights from studies of vascular biology., Circulation 1994;90:2126-2146.
3. Badimon JJ., Badimon L, Galvez A, Dische R, Fustcr V: The high density lipoprotein plasma functions inhibit aortic fatty streak in cholesterol-fed rabbits., Lab Invest 1989,60: 455-461.
4. Badimon JJ, Badimon L, Fustcr V: Regression of atherosclerotic lesions by high density lipoprotein plasma fractions in the cholesterol-fed rabbit., J Clin Invest 1990;85:1234-1241.
5. Amcli S, Hultgardh-Nilsson A, Cer-cek B, Shah PK, Forrester JS, Age-land H, Nilsson J: Recombinant apolipoprotein A-l Milano reduces intimal thickening after balloon injury in hypercholesterolcmic rabbits., Circulation 1994:90:1935-1941.
6. Scandinavian Simvastatin Survival Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)., Lancet 1994;344:1383-1389.
7. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimcr AR., MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia., West of Scotland Coronary Prevention Study Group., N Engl’ J Med 1995:333:1301-1307.
8. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabowcr ME, Ko-sinski AS, Zhang J, Boccuzzi SJ, Ce-darholm JC, Alexander RW: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease., N Engl J Med 1995; 332:481-487.
9. Brown BG, Zhao X-Q, Sacco DE, Albers JJ: Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease., Circulation 1993;87:1781-1791.
10. Blankcnhorn DH, Hodis HN: George Lyman Duff Memorial Lecture., Arterial imaging and atherosclerosis reversal., Arterioscler Thromb 1994:14:177-192.
11. Uren NG, Melin JA, De Bruync B, Wijns W, Baudhuin T, Camici PG: Relation between myocardial blood flow and the severity of coronary-artery stenosis., N Engl J Med 1994; 330: 1782-1788.
12. Gould KL, Ornish D, Schcrwitz L, Brown S, Edens RP, Hess MJ, Mul-lani N, Bolomcy L, Dobbs F, Armstrong WT: Changes in myocardial perfusion abnormalities by positron emission tomography after longterm, intense risk factor modification., J Am Med Assoc 1995;274: 894-901.
13. Davies MJ., Richardson PD, Woolf N, Katz DR, Mann J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content., Br Heart J 1993;69: 377-381.
14. Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia A, Palacios IF., Gold HK, Mehran R, Shama SK., Nemerson Y, Fustcr V, Fallon JT: Macrophages, smooth muscle cells and tissue factor in unstable angina: implications for cell mediated thrombogenicity in acute coronary syndromes., Circulation 1996;94; 3090-3097.
15. Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V: Platelet thrombus formation on collagen type 1: a model of deep vessel injury: influence of blood rheology, von Willebrand factor, and blood coagulation., Circulation 1988,78: 1432-1442.
16. Badimon L, Badimon JJ: Mechanisms of arterial thrombosis in nonparallel streamlines., Platelet thrombi grow on the apex of stenotic severely injured vessel wall., J Clin Invest 1989:84:1134-1144.
17. Fuster V, Badimon L, Badimon JJ, Chcscbro J: The pathogenesis of coronary artery disease and acute coronary syndromes., N Engl J Med 1992:326:242-250.
18. Hayes RM, Badimon JJ, Coller BS, Sharma SK, Duvvuri S, Gallo R, Marmur J, Badimon L, Fallon JT, Fuster V, Chesebro JH: c7E3 alone is as effective as c7E3 plus heparin in reducing thrombus formation., Circulation 1996;94(suppl 1):435.
19. Kyrle PA, Chesebro JH, Hayes RM, Rubsamcn K, Fuster V., Badimon JJ: Antithrombotic effect of PEG-hirudin compared to heparin and heparin plus c7E3., Circulation 1997; in press.
20. Mailhac A, Badimon JJ, Fallon JT, Femandez-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L: Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis: relative contribution of fibrin(ogen) and platelets., Circulation 1994:90.988-996.
21. Toschi V, Gallo R, Lettino M, Fallon JT, Gcrtz SD, Fcrnandcz-Ortiz A, Chesebro JH, Badimon L, Ne-merson Y., Fuster V, Badimon JJ: Tissue factor modulates the throm-bogcnicity of human atherosclerotic plaques., Circulation 1997;95:594-599.
22. Meyer BJ., Badimon JJ., Mailhac A., Fernandez-Ortiz A, Chesebro JH, Fuster V, Badimon L: Inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy., Circulation 1994:90:2432-2438.
23. Wysokinski W, McBane R, Chesebro JH., Owen WG: Reversibility of platelet thrombosis in vivo., Quantitative analysis in porcine carotid arteries., Thromb Haemost 1996;76: 1108-1113.
24. Gallo R., Fallon JT, Toschi V, Gcrtz SD, Ncmcrson Y, Chesebro JH, Fuster V, Badimon JJ., Biphasic increase of tissue factor activity after angioplasty in porcine coronary’ arteries., Circulation 1995;92(suppl 1): 1-354.
25. Gertz SD., Fallon JT, Barry WL, Gallo R., Gimple LW, Nemerson Y., Thiruvikraman SV, Taubman M, Badimon JJ, Chesebro JH, Fuster V: Tissue factor activity after angioplasty in atherosclerotic rabbits: Inhibition by hirudin., Circulation 1995;92(suppl D):1-805.
26. Badimon L, Lassila R, Badimon J, Fuster V: An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall., J Am Coll Cardiol 1990; 15(supp 1): 181A.
27. Badimon JJ, Badimon L, Turitto VT, Fuster V: Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels., Arterioscl-er Thromb 1991;11:395-402.
28. Lacoste LL, Lam JYT, Hung J, Waters D: Pravachol decreases thrombus formation in hypcrcholcsterol-emic coronary patients in conjunction with improvements in serum lipids., J Am Coll Cardiol 1994:23: 131A.
29. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction., Ann Intern Med 1997;126:296-306.
30. Mansfield MW, Hcywood DM, Grant PJ: Circulating levels of factor VII., fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM., Circulation 1996;94:2171-2176.
31. Kazmier FJ, Fuster V, Chesebro JH, O’Fallon WM, Palumbo PJ: Platelet survival half-life in diabetes mcllitus with and without peripheral arterial occlusive disease., Thromb Haemost 1979:42:384.
32. Medina PA, Bauer KA, Oltrona L, Ardissino D, Cattanco M, Belli C, Mannucci PM, Rosenberg RD: Persistent activation of coagulation mechanism in unstable angina and myocardial infarction., Circulation 1994;90:61-68.
33. Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group., Low molecular weight heparin during instability in coronary artery disease., Lancet 1996:347:561-568.
34. Cohen M, Adams PC, Parry G, Xiong J., Chamberlain D, Wicczorck I, Fox KAA., Chesebro JH., Strain J, Keller C, Kelly A, Lancaster G, Ali J, Kronmal R, Fuster V, and the Antithrombotic Therapy in Acute Coronary Syndromes Research Group: Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users., Primary end points analysis from the ATACS Trial., Circulation 1994;89:81-88.
35. Williams MJA, Morrison IM, Parker JH, Stewart RAH: Progression of the culprit lesion in unstable coronary’ artery disease with warfarin and aspirin versus aspirin alone: preliminary study., J Am Coll Cardiol 1997;30:367-369.
36. Gallo R, Toschi V, Fallon JT., Chesebro JH, Fuster V., Badimon JJ: Prolonged thrombin inhibition reduces neointima formation after balloon angioplasty in porcine coronary arteries., Circulation 1997; in press